{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:31:42Z","timestamp":1791189102569,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2010-21130"],"award-info":[{"award-number":["BFU2010-21130"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2013-47242-R"],"award-info":[{"award-number":["BFU2013-47242-R"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["BFU2010-20664"],"award-info":[{"award-number":["BFU2010-20664"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PNSD"},{"name":"7th Framework Programme (Capacities)","award":["-REGPOT-2012-CT2012-31637-IMBRAIN"],"award-info":[{"award-number":["-REGPOT-2012-CT2012-31637-IMBRAIN"]}]},{"DOI":"10.13039\/100007650","name":"Fundaci\u00f3n Canaria de Investigaci\u00f3n y Salud","doi-asserted-by":"publisher","award":["ID54"],"award-info":[{"award-number":["ID54"]}],"id":[{"id":"10.13039\/100007650","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Agencia Canaria de Investigaci\u00f3n","award":["SE-10\/19"],"award-info":[{"award-number":["SE-10\/19"]}]},{"name":"Innovaci\u00f3n y Sociedad de la Informaci\u00f3n","award":["CEI 10\/00018-EDU\/903\/2010"],"award-info":[{"award-number":["CEI 10\/00018-EDU\/903\/2010"]}]},{"name":"Campus de Excelencia Internacional (FEDER, ULL"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.nbd.2014.12.007","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T04:19:16Z","timestamp":1418357956000},"page":"325-335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake"],"prefix":"10.1016","volume":"74","author":[{"given":"Javier","family":"Castro-Hern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domingo","family":"Afonso-Oramas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Cruz-Muros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josmar","family":"Salas-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Barroso-Chinea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Moratalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Millan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Gonz\u00e1lez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.12.007_bb0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1073\/pnas.93.5.1945","article-title":"A targeted mutation on the D3 dopamine receptor gene is associated with hyperactivity in mice","volume":"93","author":"Accili","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.12.007_bb0010","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nbd.2009.09.002","article-title":"Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease","volume":"36","author":"Afonso-Oramas","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.12.007_bb0015","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.nbd.2010.07.012","article-title":"The dopamine transporter is differentially regulated after dopaminergic lesion","volume":"40","author":"Afonso-Oramas","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.12.007_bb0020","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1185\/03007990903364954","article-title":"Potential neuroprotection mechanisms in PD: focus on dopamine agonist pramipexole","volume":"25","author":"Albrecht","year":"2009","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.nbd.2014.12.007_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jad.2012.03.007","article-title":"Greater striatal dopamine transporter binding in major depressive disorder","volume":"141","author":"Amsterdam","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.nbd.2014.12.007_bb0030","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1074\/jbc.M113.531632","article-title":"Single molecule analysis reveals coexistence of stable serotonin transporter monomers and oligomers in the live cell plasma membrane","volume":"289","author":"Anderluh","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0035","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1242\/jcs.116293","article-title":"COUP-TFII orchestrates venous and lymphatic endothelial identity by homo- or hetero-dimerisation with PROX1","volume":"126","author":"Aranguren","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2014.12.007_bb0040","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bjc.6605836","article-title":"In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein\u2013protein complexes in paraffin sections from breast cancer tissues","volume":"103","author":"Aubele","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.nbd.2014.12.007_bb0045","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1523\/JNEUROSCI.0387-04.2004","article-title":"Methamphetamine increases dopamine transporter higher molecular weight complex formation via a dopamine- and hyperthermia-associated mechanism","volume":"24","author":"Baucum","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.12.007_bb0050","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1471-4159.2008.05406.x","article-title":"Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2\/D3 receptor activation","volume":"106","author":"Bellucci","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0055","doi-asserted-by":"crossref","first-page":"e27959","DOI":"10.1371\/journal.pone.0027959","article-title":"Redistribution of DAT\/ \u03b1-synuclein complexes visualized by \u201cin situ\u201d proximity ligation assay in transgenic mice modelling early Parkinson's disease","volume":"6","author":"Bellucci","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.12.007_bb0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1124\/mol.106.027763","article-title":"D2 receptors regulate dopamine transporter function via an extracellular signal-regulated kinases 1 and 2-dependent and phosphoinositide 3 kinase-independent mechanism","volume":"71","author":"Bolan","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0065","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1523\/JNEUROSCI.5094-09.2010","article-title":"Dysregulation of dopamine transporter via D2 autoreceptor triggers anomalous dopamine efflux associated with attention-deficit hyperactivity disorder","volume":"30","author":"Bowton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.12.007_bb0070","doi-asserted-by":"crossref","first-page":"24769","DOI":"10.1074\/jbc.M603877200","article-title":"Serotonin-, protein kinase C-, and Hic-5-associated redistribution of the platelet serotonin transporter","volume":"281","author":"Carneiro","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0075","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1073\/pnas.0610964104","article-title":"Physical interaction between the serotonin transporter and neuronal nitric oxide synthase underlies reciprocal modulation of their activity","volume":"104","author":"Chanrion","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.12.007_bb0080","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/jnc.12229","article-title":"Protein kinase C\u03b2 is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter","volume":"125","author":"Chen","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0085","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/npp.2008.114","article-title":"Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain","volume":"34","author":"Chernoloz","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.12.007_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00213-007-0766-3","article-title":"Yawing and hypothermia in rats: effects of dopamine D3 and D2 agonists and antagonists","volume":"193","author":"Collins","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2014.12.007_bb0095","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1471-4159.2011.07618.x","article-title":"Pre-synaptic dopamine D (3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways","volume":"120","author":"Collo","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.neurobiolaging.2007.09.009","article-title":"Aging effects on the dopamine transporter expression and compensatory mechanisms","volume":"30","author":"Cruz-Muros","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.12.007_bb0105","doi-asserted-by":"crossref","first-page":"e636","DOI":"10.4088\/JCP.12m08093","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole augmentation in treatment-resistant major depressive disorder","volume":"74","author":"Cusin","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2014.12.007_bb0110","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.20-23-08677.2000","article-title":"Dopamine D3 receptors expressed by all mesencephalic dopamine neurons","volume":"20","author":"Diaz","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.12.007_bb0115","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1471-4159.2010.06599.x","article-title":"Regulation of dopamine transporter function by protein\u2013protein interactions: new discoveries and methodological challenges","volume":"113","author":"Ericksen","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tips.2011.12.003","article-title":"GRK2: multiple roles beyond G protein-coupled receptor desensitization","volume":"33","author":"Evron","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.nbd.2014.12.007_bb0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2014.01.025","article-title":"The role of D2-autoreceptors in regulating dopamine neuron activity and transmission","volume":"282C","author":"Ford","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.12.007_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3565(25)38490-9","article-title":"Expression and pharmacological characterization of the human D3 dopamine receptor","volume":"268","author":"Freedman","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2014.12.007_bb0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/cne.20323","article-title":"Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons","volume":"479","author":"Gonzalez-Hernandez","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","article-title":"Dopamine D2-receptor knockout mice are protected against dopamine neurotoxicity induced by methamphetamine or MDMA","volume":"42","author":"Granado","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.12.007_bb0145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/jpet.108.145631","article-title":"Mechanisms underlying methamphetamine-induced dopamine transporter complex formation","volume":"329","author":"Hadlock","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2014.12.007_bb0150","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jneumeth.2011.01.023","article-title":"Ex vivo identification of protein\u2013protein interactions involving the dopamine transporter","volume":"196","author":"Hadlock","year":"2011","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2014.12.007_bb0155","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1073\/pnas.181344298","article-title":"Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment","volume":"98","author":"Hastrup","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2014.12.007_bb0160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4522(02)00067-2","article-title":"Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors","volume":"112","author":"Joseph","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.12.007_bb0165","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2006.11.004","article-title":"Dopamine D3 receptor agonists for protection and repair in Parkinson's disease","volume":"7","author":"Joyce","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1741-7007-2-22","article-title":"Low dose pramipexole is neuroprotective in the MPTP model of Parkinson's disease, and downregulates the dopamine transporter via D3 receptor","volume":"2","author":"Joyce","year":"2004","journal-title":"BMC Biol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-2999(01)00902-5","article-title":"Release and aggregation of cytochrome c and alpha-synuclein are inhibited by antiparkinsonian drugs, talipexole and pramipexole","volume":"417","author":"Kakimura","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0180","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0896-6273(00)80351-7","article-title":"Pituitary lactotroph hyperplasia and chronic hyperprolactinemia in dopamine D2 receptor-deficient mice","volume":"19","author":"Kelly","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.12.007_bb0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00213-008-1323-4","article-title":"The discriminative stimulus of D2- and D3-preferring agonists in rats","volume":"203","author":"Kofarnus","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.nbd.2014.12.007_bb0190","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/sj.emboj.7601656","article-title":"Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor","volume":"26","author":"Lee","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2014.12.007_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.coph.2009.10.001","article-title":"Dopamine D2\u2013D3 receptor heteromers: pharmacological properties and therapeutic significance","volume":"10","author":"Maggio","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0200","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2010.06.002","article-title":"From the cell to the clinic: a comparative review of the partial D2\/D3 receptor agonist and \u03b12-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease","volume":"128","author":"Millan","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2014.12.007_bb0205","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1124\/jpet.109.165084","article-title":"Characterization of the transport, metabolism, and pharmacokinetics of the dopamine D3 receptor-selective fluorenyl- and 2-pyridylphenyl amides developed for treatment of psychostimulant abuse","volume":"333","author":"Mason","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2014.12.007_bb0210","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0028-3908(99)00180-X","article-title":"Discriminative stimulus properties of the dopamine D3 receptor agonists, PD128,907 and 7-OH-DPAT: a comparative characterization with novel ligands at D3 and D2 receptors","volume":"39","author":"Millan","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2014.12.007_bb0215","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/bph.12357","article-title":"Novel roles of \u03b2-arrestins in the regulation of pharmacological sequestration to predict agonist-induced desensitization of dopamine D3 receptors","volume":"170","author":"Min","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mi.7.3.7","article-title":"Regulation of receptors and transporters by ubiquitination: new insights into surprisingly similar mechanisms","volume":"7","author":"Miranda","year":"2007","journal-title":"Mol. Interv."},{"key":"10.1016\/j.nbd.2014.12.007_bb0225","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2003.08.066","article-title":"Dynamic regulation of the dopamine transporter","volume":"479","author":"Mortensen","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0230","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0893-133X(96)00095-4","article-title":"Chronic fluoxetine reduces serotonin transporter mRNA and 5-HT1B mRNA in a sequential manner in the rat dorsal raphe nucleus","volume":"15","author":"Neumaier","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2014.12.007_bb0235","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1001\/archneurol.2009.32","article-title":"Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease","volume":"66","author":"Parkinson Study Group CALM cohort investigators","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0014-2999(96)00454-2","article-title":"Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists","volume":"312","author":"Piercey","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0245","doi-asserted-by":"crossref","first-page":"e44316","DOI":"10.1371\/journal.pone.0044316","article-title":"Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation","volume":"7","author":"Platania","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2014.12.007_bb0250","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0197-4580(03)00129-5","article-title":"Decreased plasma membrane expression of striatal dopamine transporter in aging","volume":"24","author":"Salvatore","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2014.12.007_bb0255","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1042\/bst0290732","article-title":"Impact of oligomerization on the function of the human serotonin transporter","volume":"29","author":"Schmid","year":"2001","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.nbd.2014.12.007_bb0260","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ymeth.2008.06.014","article-title":"Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay","volume":"45","author":"S\u00f6derberg","year":"2008","journal-title":"Methods"},{"key":"10.1016\/j.nbd.2014.12.007_bb0265","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/187152706784111551","article-title":"The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord","volume":"5","author":"Sokoloff","year":"2006","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2014.12.007_bb0270","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/347146a0","article-title":"Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics","volume":"347","author":"Sokoloff","year":"1990","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2014.12.007_bb0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-4159.2006.03719.x","article-title":"The dopamine transporter proteome","volume":"97","author":"Torres","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0280","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1021\/ci1002747","article-title":"Subtype selectivity of dopamine receptor ligands: insights from the structure and ligand-based methods","volume":"50","author":"Wang","year":"2010","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.nbd.2014.12.007_bb0285","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0304-3940(03)00212-X","article-title":"Attenuation of dopamine transporter activity by alpha-synuclein","volume":"340","author":"Wersinger","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.12.007_bb0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semcdb.2009.01.004","article-title":"Trafficking of dopamine transporter in psychostimulant actions","volume":"20","author":"Zahniser","year":"2009","journal-title":"Sem. Cell. Dev. Biol."},{"key":"10.1016\/j.nbd.2014.12.007_bb0295","doi-asserted-by":"crossref","first-page":"35842","DOI":"10.1074\/jbc.M611758200","article-title":"Regulation of dopamine transporter function and cell surface expression by D3 dopamine receptors","volume":"282","author":"Zapata","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0300","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1471-4159.2002.00893.x","article-title":"D3 receptor ligands modulate extracellular dopamine clearance in the nucleus accumbens","volume":"81","author":"Zapata","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.12.007_bb0305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuropharm.2004.09.003","article-title":"Lack of functional D2 receptors prevents the effects of D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels","volume":"48","author":"Zapata","year":"2005","journal-title":"Neuropharmacology"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114003787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114003787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:08:04Z","timestamp":1760850484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114003787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":61,"alternative-id":["S0969996114003787"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.12.007","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}